U.S. Metals and Mining Stock News

Certara (CERT) has just wrapped up FY 2025 with fourth quarter revenue of US$103.6 million and a basic EPS loss of US$0.04, as net income excluding extra items came in at a loss of US$5.9 million. The company has seen quarterly revenue move from US$100.4 million in Q4 2024 to US$106.0 million in Q1 2025, US$104.6 million in Q3 2025 and US$103.6 million in Q4 2025, while basic EPS has swung between a profit of US$0.04 in Q4 2024 and Q1 2025 and losses of up to US$0.04 in Q4 2025. Investors are...

Flowco Holdings (FLOC) has wrapped up FY 2025 with fourth quarter revenue of US$197.2 million and basic EPS of US$0.60, alongside trailing 12 month net profit margin of 5.4% compared with 15% in the prior year. The company has seen revenue move from US$535.3 million on a trailing 12 month basis in Q4 2024 to US$759.7 million in Q4 2025, while trailing EPS shifted from US$10.41 to US$1.53, leaving investors with a mixed read on growth versus profitability. With earnings forecasts pointing to...

Winmark (WINA) has wrapped up FY 2025 with fourth quarter revenue of about US$21.1 million and basic EPS of US$2.79, capping a trailing twelve month revenue line of US$86.1 million and EPS of US$11.73. The company has seen revenue move from US$81.3 million to US$86.1 million over recent trailing periods, while trailing twelve month net income has shifted from US$40.0 million to US$41.7 million, giving investors a clear read on how the top and bottom lines are tracking into the latest print...

Fortrea Holdings (FTRE) closed FY 2025 with fourth quarter revenue of US$660.5 million, a basic EPS loss of US$0.35 and net income loss of US$32.5 million. Over recent periods, the company has seen quarterly revenue move between US$651.3 million and US$710.3 million while basic EPS ranged from a loss of US$0.17 through to a much deeper quarterly loss of US$6.25. This sets a clear context for how you might read the latest numbers. With trailing 12 month EPS at a loss of US$10.81 and net income...

If you are wondering whether Walt Disney shares are offering good value right now, this article walks through the key numbers so you can judge the price with more confidence. The stock most recently closed at US$105.55, with a 0.4% decline over 7 days, a 4.6% decline over 30 days, a 5.6% decline year to date, and a 4.1% decline over the past year, while the 3 year return sits at 9.2% and the 5 year return at a 42.5% decline. Recent headlines around Walt Disney have focused on the ongoing...

NextEra Energy (NYSE:NEE) launched a $2b public offering of equity units to fund energy and power projects, including data center focused initiatives. The offering is tied to the company’s plans to support large scale data center power generation alongside partners such as Google and Exxon. The move comes as the company outlines a higher long term earnings outlook and expands its role in supplying power to energy intensive digital infrastructure. For investors watching NYSE:NEE, this...

Valero Energy (NYSE:VLO) is preparing to import a large volume of Venezuelan crude oil into its Gulf Coast refineries. This move marks a change in crude sourcing for its U.S. refining system at a time of shifting global energy trade flows. Investors are watching how this feedstock mix could affect refinery utilization, margins, and relationships with other suppliers. Valero enters this development with a current share price of $203.79 and a 1-year return of 61.8%, while its 5-year return...

Perimeter Solutions (PRM) has just posted its FY 2025 numbers with Q4 revenue of US$102.8 million and a basic EPS loss of US$0.94, while trailing 12 month revenue stood at US$652.9 million and basic EPS came in at a loss of US$1.37. Looking back over the recent periods, the company has seen quarterly revenue move from US$86.2 million and EPS of US$0.98 in Q4 2024 to US$72.0 million with EPS of US$0.38 in Q1 2025, then US$162.6 million with EPS of US$0.22 loss in Q2 2025 and US$315.4 million...

Veeco Instruments (VECO) has wrapped up FY 2025 with fourth quarter revenue of US$165.0 million and basic EPS of US$0.02, alongside trailing twelve month revenue of US$664.3 million and EPS of US$0.60 that frame the full year picture. The company has seen quarterly revenue move from US$182.1 million and EPS of US$0.26 in Q4 2024 to US$165.0 million and EPS of US$0.02 in Q4 2025, with trailing net profit margin at 5.3% compared with 10.3% a year earlier. Investors are therefore likely to focus...

StandardAero FY 2025 Earnings Snapshot StandardAero (SARO) has wrapped up FY 2025 with fourth quarter revenue of US$1.6 billion, basic EPS of US$0.24 and net income of US$78.6 million. This capped a year in which trailing twelve month EPS reached US$0.84 on revenue of US$6.1 billion and net income of US$277.4 million, alongside very large year over year earnings growth. Over the last six reported quarters, the company has seen quarterly revenue move from US$1.41 billion in Q4 2024 to US$1.60...

XPEL (XPEL) closed out FY 2025 with Q4 revenue of US$122.3 million and basic EPS of US$0.49, alongside trailing twelve month revenue of US$476.2 million and EPS of US$1.85. The company has seen revenue move from US$107.5 million and EPS of US$0.32 in Q4 2024 to US$122.3 million and EPS of US$0.49 in Q4 2025, setting up a story where consistent top line expansion is paired with earnings that keep pace and margins that hold steady rather than drift. See our full analysis for XPEL. With the...

Delcath Systems (DCTH) has wrapped up FY 2025 with fourth quarter revenue of US$20.7 million and a basic EPS loss of US$0.05, alongside net income of US$1.9 million in the red, giving investors a mixed headline for the latest period. The company has seen revenue move from US$15.1 million in Q4 2024 to US$20.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.11 to a smaller loss of US$0.05. This sets up a picture where top line scale and bottom line volatility put the focus...

On February 25, 2026, Recursion Pharmaceuticals reported full-year 2025 results showing revenue of US$74.68 million, a net loss of US$644.76 million, and simultaneously filed a US$300 million at-the-market follow-on offering plus a US$68.57 million shelf registration for 19,424,000 Class A shares tied to employee plans. Alongside beating fourth-quarter loss and revenue expectations, management stated that cost controls and partnerships have extended Recursion’s cash runway into early 2028...

MYR Group (MYRG) has wrapped up FY 2025 with fourth quarter revenue of US$973.5 million and basic EPS of US$2.35, while trailing twelve month revenue sits at about US$3.7 billion with basic EPS of US$7.57, setting a clear earnings season marker for investors. The company has seen quarterly revenue move from US$829.8 million in Q4 2024 to US$973.5 million in Q4 2025, with basic EPS over that span shifting from US$0.99 to US$2.35. Trailing net profit margin sits at 3.2% versus 0.9% a year...

Hilton Grand Vacations FY 2025 Earnings Snapshot Hilton Grand Vacations (HGV) closed out FY 2025 with fourth quarter revenue of US$1.3b and basic EPS of US$0.56, alongside net income of US$48m. For the year, trailing twelve month EPS reached US$0.90 on revenue of US$5.0b and net income of US$81m. The company reported an increase in quarterly revenue from US$1.1b and EPS of US$0.20 in Q4 2024 to US$1.3b and EPS of US$0.56 in Q4 2025. The latest twelve month net margin is 1.6%, compared with...

Donaldson (DCI) just posted its Q2 2026 scorecard, with revenue of US$896.3 million and basic EPS of US$0.80, set against trailing twelve month revenue of US$3.8 billion and EPS of US$3.24 that frame the latest quarter in a broader run of results. Over recent quarters, revenue has moved between US$870 million and US$980.7 million while quarterly EPS has ranged from US$0.49 to just under US$0.99, giving investors a clearer view of how the current print sits within the recent earnings pattern...

Schrödinger (SDGR) closed out FY 2025 with Q4 revenue of US$87.2 million, Basic EPS of US$0.44 and net income of US$32.5 million, marking a clear contrast with the loss making quarters that opened the year. Over the past few periods, the company has seen quarterly revenue move from US$59.6 million in Q1 2025 to US$54.8 million in Q2, US$54.3 million in Q3 and then US$87.2 million in Q4. EPS shifted from a loss of US$0.82 in Q1 to losses of US$0.59 and US$0.45 in Q2 and Q3, before turning...

Glacier Bancorp (GBCI) just closed FY 2025 with fourth quarter revenue of US$266.9 million and basic EPS of US$0.49, alongside full year trailing twelve month revenue of US$952.7 million and EPS of US$2.00 that reflected 25.7% earnings growth over the past year. Over recent periods, revenue has moved from US$802.5 million to US$952.7 million on a trailing twelve month basis, while EPS has gone from US$1.68 to US$2.00. This sets up a story that now centers on how sustainable those margins and...

Latest FY 2025 results set up a new phase for Vistance Networks (VISN) Vistance Networks (VISN) closed FY 2025 with Q4 total revenue of US$2.2 billion and basic EPS of a US$0.54 loss, while trailing twelve month EPS came in at US$1.16 on net income from ongoing operations of US$255.4 million. Over recent quarters the company has seen revenue move from US$1.17 billion in Q4 FY 2024 to US$1.11 billion in Q1 FY 2025, US$1.39 billion in Q2 and US$1.63 billion in Q3, before the Q4 step up. Over...

SolarEdge’s FY 2025 Numbers Put Profitability Back Under the Microscope SolarEdge Technologies (SEDG) closed FY 2025 with Q4 revenue of US$335.4 million and a basic EPS loss of US$2.21, alongside a quarterly net loss of US$132.1 million. On a trailing twelve month basis, revenue was US$1.18 billion with a net loss of US$405.4 million and basic EPS at a loss of US$6.88. Over recent quarters the company has seen revenue move from US$235.4 million in Q3 FY 2024 to US$196.2 million in Q4 FY 2024,...

Latest FY 2025 Results Set Up Margin Story For Akebia Therapeutics (AKBA) Akebia Therapeutics (AKBA) closed FY 2025 with Q4 revenue of US$57.6 million and a basic EPS loss of US$0.05, alongside trailing 12 month revenue of US$236.2 million and a trailing basic EPS loss of US$0.02. This puts the focus firmly on how efficiently that revenue is being converted into earnings. The company has seen quarterly revenue move from US$37.4 million in Q3 2024 to a range of US$57.3 million to US$62.5...

Fate Therapeutics (FATE) closed out FY 2025 with Q4 revenue of US$1.4 million and a basic EPS loss of US$0.27, alongside a net loss of US$32.4 million. On a trailing 12 month basis, the company recorded revenue of US$6.6 million and a basic EPS loss of US$1.15 tied to a net loss of US$136.3 million. Over recent quarters, the business has seen quarterly revenue range between US$1.4 million and US$1.9 million and quarterly basic EPS losses move between US$0.27 and US$0.32. This keeps the focus...

Maravai LifeSciences Holdings (MRVI) has wrapped up FY 2025 with fourth quarter revenue of US$49.9 million and a basic EPS loss of US$0.25, set against a trailing twelve month loss of US$0.91 per share on revenue of US$185.7 million. Over recent quarters the company has seen revenue move from US$56.4 million in Q4 2024 to US$41.6 million in Q3 2025 and then to US$49.9 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.19 in Q4 2024 to losses between US$0.18 and US$0.27...

If you are wondering whether Black Hills at around US$73.83 is offering fair value or a potential mispricing, you are not alone in asking that question right now. The stock has returned 1.0% over the last 7 days, 0.3% over 30 days, 6.0% year to date and 27.5% over 1 year, with a 36.7% return over 3 years and 50.7% over 5 years, which gives useful context before comparing price with underlying value. Recent news around Black Hills has largely focused on its position in the regulated utilities...